Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Biphenotypic, Acute 2Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

pegfilgrastim 3Leucovorin 2Fluorouracil 2Filgrastim 2Ciprofloxacin 2pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Tretinoin 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Moxibustion 1Mitoxantrone 1Maxy G34 1Levofloxacin 1Irinotecan 1Idarubicin 1Etoposide 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cefepime 1Amsacrine 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neutropenia × Thioguanine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡